Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 512
Selected: 0
NCT IDTitle
NCT06445192Evaluating the Impact of a Virtually Supervised Exercise Intervention and Group Counseling on Inflammation and the Microbiome of Smokers at High Risk for Lung Cancer, BE FIT Trial
NCT04836832Acalabrutinib and Duvelisib for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
NCT05304793Testing a Cognitive Behavioral Model for Reducing Dyspnea in Patients With Lung Cancer
NCT00293527Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma
NCT05972941Nicotine and Tobacco Message Framing Among LGBT Young Adults
NCT07594678Minoxidil With or Without Low-Level Red-Light Therapy for Improving Chemotherapy-Induced Alopecia in Breast Cancer Patients
NCT04439006Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization
NCT01129206Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy
NCT00201773Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer
NCT05243069Head and Neck Cancer Patient Symptom and Oncologic Outcomes
NCT01559194Low Fat Versus Protein Sparing Diet for Weight Loss & Impact on Biomarkers Associated With Breast Cancer Risk
NCT03786354Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer
NCT06630429A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors
NCT05114005Tango for Neuropathy Among Breast Cancer Survivors
NCT03943342Ibrutinib and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia After Ibrutinib Resistance
NCT00003041Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer
NCT07346092Studying the Health Perceptions and Social Behaviors of Graduate Students at the Ohio State University for the Development of Effective Oral Nicotine Pouch Addictive Risk Communication
NCT07581041Studying the Impacts of Higher Taxes and Bans on Electronic Cigarettes to Improve Public Health
NCT02122081Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies
NCT00754910Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Non-Small Cell Lung Cancer And Bronchial Disease
NCT05717998Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury After Thoracic Radiation Therapy
NCT03460483Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care
NCT04022616Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
NCT02940301Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
NCT00989586Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
NCT06906562A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
NCT01569672Ohio Patient Navigator Research Program
NCT03656835Nanochip Technology in Monitoring Treatment Response and Detecting Relapse in Participants With Diffuse Large B-Cell Lymphoma
NCT03525925Ibrutinib and Nivolumab in Treating Participants With Metastatic Solid Tumors
NCT07619391MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer
NCT01172561Community Awareness Resources and Education - Project 1
NCT01282580Dietary Fish and Omega 3 Fatty Acids for Breast Cancer Prevention
NCT06616623Vismodegib and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
NCT01535924Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma
NCT00738361Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery
NCT05981209Elotuzumab, CC-92480, and Dexamethasone for the Treatment of Relapsed or Refractory Myeloma After CD38- and BCMA-Targeted Therapies
NCT04518345TP-0903 for the Treatment of FLT3 Mutated Acute Myeloid Leukemia
NCT07215065Examining Heavy Metal Exposure and Respiratory Health in Young Adult Electronic Cigarette Users
NCT03328936Study of Personalized Melphalan Dosing in the Setting of Autologous Transplant
NCT02960100mHealth Intervention in Increasing HPV Vaccinations in College Students
NCT04754321Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer
NCT05417165Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia
NCT00983944Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma
NCT07216534Virtual Reality Viewing of Unaltered Streetscape Versus Digitally Manipulated Opposite Streetscape to Assess Psychosocial Response in Participants
NCT02013492Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery
NCT04713618Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy
NCT02120222Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery
NCT01462773Study of Patients With Stage IV Malignant Melanoma Using PS-341 (Bortezomib, Velcade) and Interferon-alpha-2b in Malignant Melanoma
NCT04919369All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
NCT07609030A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma